Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)

SIMPLE SUMMARY: The only vaccine approved by FDA as a treatment for cancer is sipuleucel-T, a therapy for patients with metastatic castration-resistant prostate cancer (mCRPC). Most investigators studying anti-tumor vaccines believe they will be most effective as parts of combination therapies, rath...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Gamat-Huber, Melissa, Jeon, Donghwan, Johnson, Laura E., Moseman, Jena E., Muralidhar, Anusha, Potluri, Hemanth K., Rastogi, Ichwaku, Wargowski, Ellen, Zahm, Christopher D., McNeel, Douglas G.
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7601088/
https://ncbi.nlm.nih.gov/pubmed/33008010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102831
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky